# Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections

> **NCT07704333** · PHASE1 · RECRUITING · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 98 (estimated)

## Conditions studied

- Aspergillos
- Mucormye
- Dimorphic
- Other Molds
- Non-Aspergillos
- Non-Mucormycosis

## Interventions

- **DRUG:** [18F]-Fluorocellobiose ([18F]FCB)

## Key facts

- **NCT ID:** NCT07704333
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-09
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2026-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704333, "Assessment of [18F]-Fluorocellobiose ([18F]FCB) Pharmacokinetics in Healthy Volunteers and Subjects With Invasive Mold Infections". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07704333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*